InsidersTradesSigma
東和薬品株式会社 Stock: price and directors' dealings · Japan · EDINET (Japan FSA)
Track the 東和薬品株式会社 stock price and the full directors' dealings record of the company, a publicly traded company based in Japan. Shares are quoted on JP JP, under the authority of EDINET (Japan FSA). Operating in the Health Care sector, 東和薬品株式会社 has recorded 3 reports. Market capitalisation: €194.2bn. The latest transaction was reported on 6 July 2026 (Holding update). Among the most active insiders: Sumitomo Mitsui DS Asset Management Company, Limited. All data is free.
3
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 東和薬品株式会社 Strong Buy (bullish), based on 6 analysts. Average price target: JP¥5,267.
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 17,779 of 28,102 companies
43.7
score / 100
Value53
Quality35
FCF yld3.2%
Earn yld2.7%
EV/EBITDA11.0x
ROE3.0%
Gross mgn36%
Net mgn1.9%
Debt/EBITDA5.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 6 July 2026
Declarations3 total
ShareXTKSEDINET:S100YOTO
ShareXTKSEDINET:S100XJ2X
100.0% of flowShareXTKSEDINET:S100QTZZ
3 of 3 declarations
About 東和薬品株式会社
Towa Pharmaceutical Co., Ltd. is a Japanese company specializing in the pharmaceutical sector. It focuses on the research, development, and marketing of medications.